Literature DB >> 25179983

Effectiveness of thrombopoietin-receptor agonists in the treatment of refractory immune thrombocytopenia associated to systemic lupus erythematosus.

Laura Magnano1, Hector Enríquez2, Jordi Esteve1, Ricard Cervera3, Gerard Espinosa4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25179983     DOI： 10.3899/jrheum.140080

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  4 in total

Review 1.  Current treatment of antiphospholipid syndrome: lights and shadows.

Authors:  Gerard Espinosa; Ricard Cervera
Journal:  Nat Rev Rheumatol       Date:  2015-06-30       Impact factor: 20.543

Review 2.  Cryptic conspirators: a conversation about thrombocytopenia and antiphospholipid syndrome.

Authors:  Andrew P Vreede; Paula L Bockenstedt; W Joseph McCune; Jason S Knight
Journal:  Curr Opin Rheumatol       Date:  2019-05       Impact factor: 5.006

3.  Eltrombopag for the treatment of refractory thrombocytopenia associated with connective tissue disease.

Authors:  Juan Wang; Min Dai; Qiong Fu; Sheng Chen
Journal:  Sci Rep       Date:  2021-03-09       Impact factor: 4.379

4.  Eltrombopag Improves Refractory Thrombocytopenia in a Patient with Systemic Lupus Erythematosus.

Authors:  Natsuki Shima; Keiichi Sumida; Masahiro Kawada; Akinari Sekine; Masayuki Yamanouchi; Rikako Hiramatsu; Noriko Hayami; Eiko Hasegawa; Tatsuya Suwabe; Junichi Hoshino; Naoki Sawa; Kenmei Takaichi; Kenichi Ohashi; Takeshi Fujii; Yoshifumi Ubara
Journal:  Case Rep Rheumatol       Date:  2018-08-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.